BPC-157 Research Notes
Selected PubMed sources, evidence limits, and current BioPep USA catalog and documentation status for BPC-157. Research use only.
Published BPC-157 material includes experimental wound models and recent literature reviews. Model type and study design must remain visible when interpreting those records.
Questions covered by the selected literature
- Which findings came from animal or cell models
- How recent reviews describe the size and quality of the evidence base
- Which claims remain unsupported by controlled human evidence
Evidence limits
The cited experimental paper combines in-vivo and in-vitro models; the other records are reviews. These studies do not establish a human-use indication. The FDA has not approved BPC-157 for human use.
A paper should be read according to its own model, methods, controls, and endpoints. Cell, animal, analytical, review, and human records are not interchangeable.
Regulatory reference
The FDA review of BPC-157-related bulk drug substances discusses regulatory status and limitations of the available evidence. Research findings do not authorize use of BioPep USA products in people or animals.
Selected PubMed sources
- Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.. Drug Des Devel Ther. 2015. PMID: 25995620.
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.. Pharmaceuticals (Basel). 2025 Jan 30. PMID: 40005999.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.. HSS J. 2025 Jul 31. PMID: 40756949.
BioPep USA record
BioPep USA currently lists BPC-157. Use the product page for current options and the documentation page for lot records.
Last reviewed: September 15, 2026.
